Kryger Capital’s Astria Therapeutics ATXS Stock Holding History

Kryger Capital’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,025,278	Closed	-$13.4M	–	77
2025 Q4	$13.4M	Buy	+1,025,278	New	+$12.2M	1.04%	19

Kryger Capital's ATXS Position: Q1 2026 in Review

Kryger Capital sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 1,025,278 shares — an estimated $13.4M sold.

Kryger Capital first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $13.4M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Kryger Capital reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Kryger Capital sold 1,025,278 Astria Therapeutics shares in Q1 2026, an estimated $13.4M.
Kryger Capital first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
Kryger Capital's Astria Therapeutics position peaked at $13.4M in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Kryger Capital's 13F filing for Q1 2026, filed 14 May 2026.